{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:27:22Z","timestamp":1792610842052,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008050","name":"Fundaci\u00f3n Cellex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014028","name":"H2020","doi-asserted-by":"publisher","award":["668031"],"award-info":[{"award-number":["668031"]}],"id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014028","name":"H2020","doi-asserted-by":"publisher","award":["731875"],"award-info":[{"award-number":["731875"]}],"id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014028","name":"H2020","doi-asserted-by":"publisher","award":["825694"],"award-info":[{"award-number":["825694"]}],"id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014028","name":"H2020","doi-asserted-by":"publisher","award":["847949"],"award-info":[{"award-number":["847949"]}],"id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.eclinm.2021.101116","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T22:56:06Z","timestamp":1630796166000},"page":"101116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)"],"prefix":"10.1016","volume":"40","author":[{"given":"Jenny","family":"Bischoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolynne","family":"Schwarze-Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Boesecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Christian","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"van Bremen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Dold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen K","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3881","authenticated-orcid":false,"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eclinm.2021.101116_bib0001","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.eclinm.2021.101116_bib0002","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/QAD.0000000000001241","article-title":"Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients","volume":"30","author":"Vuille-Lessard","year":"2016","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101116_bib0003","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/QAI.0000000000001942","article-title":"Etiology and severity of liver disease in HIV-positive patients with suspected nafld: lessons from a cohort with available liver biopsies","volume":"80","author":"Iogna Prat","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"10.1016\/j.eclinm.2021.101116_bib0004","doi-asserted-by":"crossref","first-page":"e25201","DOI":"10.1002\/jia2.25201","article-title":"Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy","volume":"21","author":"Perazzo","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"10.1016\/j.eclinm.2021.101116_bib0005","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection","volume":"31","author":"Maurice","year":"2017","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101116_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.28524","article-title":"The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health","volume":"64","author":"Rinella","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101116_bib0007","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","article-title":"Risk factors for fatty liver in the Multicenter AIDS Cohort Study","volume":"109","author":"Price","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101116_bib0008","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MCG.0b013e318264181d","article-title":"Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse","volume":"47","author":"Sterling","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101116_bib0009","doi-asserted-by":"crossref","first-page":"ofv015","DOI":"10.1093\/ofid\/ofv015","article-title":"Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patients","volume":"2","author":"Sebastiani","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101116_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/COH.0000000000000064","article-title":"Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?","volume":"9","author":"Rockstroh","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"issue":"50","key":"10.1016\/j.eclinm.2021.101116_bib0011","doi-asserted-by":"crossref","first-page":"e2127","DOI":"10.1097\/MD.0000000000002127","article-title":"Liver fibrosis in HIV patients receiving a modern cART: which factors play a role?","volume":"94","author":"Mohr","year":"2015","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.eclinm.2021.101116_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa430","article-title":"Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients","author":"Cervo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2021.101116_bib0013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-981-10-8684-7_6","article-title":"Hepatocellular carcinoma in obesity: finding a needle in the haystack?","volume":"1061","author":"Baffy","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101116_bib0014","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatol"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101116_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138838","article-title":"Progression of Liver Fibrosis in HIV\/HCV Co-Infection: a Comparison between Non-Invasive Assessment Methods and Liver Biopsy","volume":"10","author":"Schmid","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101116_bib0016","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations","volume":"60","author":"de Ledinghen","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101116_bib0017","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.eclinm.2021.101116_bib0018","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/cid\/civ192","article-title":"Weight change after antiretroviral therapy and mortality","volume":"60","author":"Yuh","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.eclinm.2021.101116_bib0019","doi-asserted-by":"crossref","first-page":"e0462","DOI":"10.1097\/MD.0000000000010462","article-title":"Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis","volume":"97","author":"Mohr","year":"2018","journal-title":"Med (Baltimore)"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101116_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s15010-018-1227-0","article-title":"A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017","volume":"47","author":"Gomez","year":"2019","journal-title":"Infect"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101116_bib0021","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/jac\/dky145","article-title":"Obesity following ART initiation is common and influenced by both traditional and HIV-\/ART-specific risk factors","volume":"73","author":"Bakal","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101116_bib0022","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","article-title":"Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens","volume":"76","author":"Norwood","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.eclinm.2021.101116_bib0023","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/QAD.0000000000001495","article-title":"Dolutegravir and weight gain: an unexpected bothering side effect?","volume":"31","author":"Menard","year":"2017","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101116_bib0024","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterol"},{"issue":"15","key":"10.1016\/j.eclinm.2021.101116_bib0025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0000000000001601","article-title":"Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults","volume":"31","author":"Price","year":"2017","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101116_bib0026","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/QAD.0000000000000248","article-title":"Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients","volume":"28","author":"Macias","year":"2014","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101116_bib0027","first-page":"1544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutr"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101116_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11904-017-0351-2","article-title":"Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in HIV","volume":"14","author":"Rockstroh","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101116_bib0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/aid.2012.0234","article-title":"Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons","volume":"29","author":"Lakey","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.eclinm.2021.101116_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab444","article-title":"Weight change following antiretroviral therapy switch in people with viral suppression: pooled data from randomized clinical trials","author":"Erlandson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101116_bib0031","doi-asserted-by":"crossref","first-page":"e25732","DOI":"10.1002\/jia2.25732","article-title":"Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study","volume":"24","author":"Martinez-Sanz","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"10.1016\/j.eclinm.2021.101116_bib0032","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2352-3018(20)30241-1","volume":"7","author":"Venter","year":"2020","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101116_bib0033","doi-asserted-by":"crossref","first-page":"e25484","DOI":"10.1002\/jia2.25484","article-title":"Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada","volume":"23","author":"Bourgi","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101116_bib0034","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/QAI.0000000000002275","article-title":"Durable efficacy of dolutegravir plus lamivudine in antiretroviral treatment-naive adults with HIV-1 infection: 96-week results from the GEMINI-1 and GEMINI-2 randomized clinical trials","volume":"83","author":"Cahn","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101116_bib0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cid\/ciy083","article-title":"Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine","volume":"67","author":"Glidden","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2021.101116_bib0036","doi-asserted-by":"crossref","DOI":"10.7326\/M20-4853","article-title":"Weight and metabolic changes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people living with HIV: a cohort study","author":"Surial","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10246","key":"10.1016\/j.eclinm.2021.101116_bib0037","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","article-title":"Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial","volume":"396","author":"Mayer","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101116_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229617","article-title":"Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight","volume":"15","author":"McMahon","year":"2020","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101116_bib0039","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41366-020-0551-5","article-title":"Potential role of the melanocortin signaling system interference in the excess weight gain associated to some antiretroviral drugs in people living with HIV","volume":"44","author":"Domingo","year":"2020","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"10.1016\/j.eclinm.2021.101116_bib0040","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterol"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021003965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021003965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:09:27Z","timestamp":1762888167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021003965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"alternative-id":["S2589537021003965"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101116","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101116"}}